Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -56.82%-15.41M | -1,126.13%-8.4M | -82.54%1.23M | -5.78%-7.25M | -859.44%-3.41M | -2.78%-9.83M | 94.05%-685K | 25.18%7.06M | 88.12%-6.86M | 97.54%-355K |
| Net profit before non-cash adjustment | 20.19%11.2M | 10.20%9.53M | 19.44%8.93M | 18.43%33.58M | -6.86%7.89M | 14.33%9.32M | 24.53%8.65M | 39.74%7.48M | 94.56%28.36M | 33.97%8.47M |
| Total adjustment of non-cash items | 105.76%2.4M | 77.62%2.07M | 57.65%1.99M | 26.07%5.74M | 165.44%2.17M | 87.14%1.16M | -38.82%1.17M | 10.52%1.26M | 43.27%4.55M | -19.97%816K |
| -Depreciation and amortization | 46.81%1.2M | 37.86%1.14M | 19.41%972K | 15.62%3.34M | 13.46%885K | 469.23%814K | -38.28%824K | 25.62%814K | 21.23%2.89M | 8.11%780K |
| -Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | 30.53%125.68K | ---- | ---- | ---- | ---- | 137.45%96.28K | ---- |
| -Disposal profit | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| -Remuneration paid in stock | --0 | --169K | --140K | 30.91%731.9K | --781K | --0 | --0 | --0 | --559.08K | --0 |
| -Other non-cash items | 242.86%1.2M | 123.98%766K | 95.97%876K | 52.77%1.55M | 1,288.89%500K | -26.93%350K | -40.11%342K | -9.33%447K | 33.67%1.01M | -86.03%36K |
| Changes in working capital | -42.82%-29M | -90.51%-20M | -476.67%-9.69M | -17.13%-46.58M | -39.61%-13.46M | -10.78%-20.31M | 48.43%-10.5M | -96.95%-1.68M | 47.32%-39.77M | 55.67%-9.64M |
| -Change in receivables | -29.40%-27.76M | -75.65%-22.78M | -902.44%-9.87M | -24.55%-47.52M | -28.58%-12.27M | -47.24%-21.45M | 27.41%-12.97M | -125.21%-985K | 49.85%-38.16M | 55.39%-9.54M |
| -Change in inventory | -144.17%-417K | -56.04%619K | 136.25%207K | 138.40%606.39K | -125.39%-1.16M | 494.98%944K | 38.17%1.41M | 68.92%-571K | -327.00%-1.58M | -212.01%-516K |
| -Change in payables | -508.91%-826K | 103.30%2.16M | 83.06%-21K | 1,155.21%338.1K | -107.99%-33K | 105.74%202K | 130.26%1.06M | 95.76%-124K | 70.27%-32.04K | 304.70%413K |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | -74.16%152.72K | 465.43%590.96K | ||||||||
| Tax refund paid | 63.99%-1.09M | -212.77%-3.97M | -7.52%-1.93M | -61.73%-10.9M | -77.34%-4.82M | -351.50%-3.02M | 39.14%-1.27M | -41.31%-1.8M | -42.39%-6.74M | -49.35%-2.72M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | -28.45%-16.49M | -532.96%-12.37M | -113.26%-698K | -38.41%-18M | -167.66%-8.23M | -25.56%-12.84M | 85.62%-1.95M | 20.49%5.26M | 79.14%-13.01M | 80.94%-3.07M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -288.79%-2.74M | -488.87%-3.49M | -112.19%-2.47M | -7.96%-2.26M | -408.77%-4.35M | 41.74%-705K | 67.88%-593K | -249.85%-1.17M | -220.02%-2.1M | -148.51%-855K |
| Net business purchase and sale | --0 | ---9.81M | ---- | --0 | --0 | --0 | --0 | ---- | ---796.2K | --0 |
| Interest received (cash flow from investment activities) | ---- | ---- | ---- | 529.55%558.69K | ---- | ---- | ---- | ---- | --88.75K | ---- |
| Investing cash flow | -288.79%-2.74M | -2,143.34%-13.3M | -112.19%-2.47M | 39.18%-1.71M | -408.77%-4.35M | 65.22%-705K | 67.88%-593K | -249.85%-1.17M | -327.94%-2.81M | -148.51%-855K |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 6,133.14%21.12M | 4,157.84%19.92M | 7,661.74%19.96M | -89.04%362.34K | 2,749.21%3.59M | -173.38%-350K | -375.84%-491K | -109.00%-264K | -87.59%3.31M | -99.51%126K |
| Net common stock issuance | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---- | 20.20%55.11M | --0 |
| Increase or decrease of lease financing | ---- | ---- | ---- | -15.92%-1.99M | ---- | ---- | ---- | ---- | -29.68%-1.72M | ---- |
| Cash dividends paid | ---3.84M | 0.00%-3.84M | ---- | -100.00%-7.68M | 0.00%-3.84M | ---- | ---3.84M | ---- | ---3.84M | ---3.84M |
| Interest paid (cash flow from financing activities) | -121.31%-1.25M | -27.45%-766K | -51.69%-895K | -4.05%-2.35M | 2.13%-596K | -0.18%-563K | -1.69%-601K | -18.71%-590K | -161.54%-2.26M | -133.61%-609K |
| Net other fund-raising expenses | -78.40%46K | ---- | -86.71%19K | 107.58%680K | -83.25%96K | 156.63%213K | 1,195.00%259K | 3,475.00%143K | -9,066.20%-8.97M | 19,200.00%573K |
| Financing cash flow | 2,396.43%16.08M | 427.71%15.32M | 2,784.53%19.09M | -128.01%-11.66M | 79.98%-751K | -34,900.00%-700K | -108.54%-4.67M | -129.15%-711K | -40.87%41.63M | -118.69%-3.75M |
| Net cash flow | ||||||||||
| Beginning cash position | -47.83%23.97M | -35.44%34.33M | -63.02%18.41M | 107.75%49.78M | -44.83%31.7M | -34.09%45.95M | 74.69%53.17M | 107.75%49.78M | 44.57%23.96M | 214.82%57.46M |
| Current changes in cash | 77.82%-3.16M | -43.39%-10.35M | 369.81%15.92M | -221.51%-31.37M | -73.55%-13.33M | -16.24%-14.25M | -118.38%-7.22M | -47.68%3.39M | 249.50%25.82M | -234.51%-7.68M |
| End cash Position | -34.35%20.81M | -47.83%23.97M | -35.44%34.33M | -63.02%18.41M | -63.09%18.37M | -44.83%31.7M | -34.09%45.95M | 74.69%53.17M | 107.75%49.78M | 107.75%49.78M |
| Free cash flow | -42.00%-19.24M | -522.69%-15.86M | -177.34%-3.17M | -34.18%-20.27M | -220.13%-12.58M | -18.44%-13.55M | 83.50%-2.55M | 1.56%4.1M | 76.03%-15.11M | 72.65%-3.93M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.